New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
07:12 EDTCVSCVS Caremark upgraded to Outperform from Neutral at Macquarie
Macquarie expects CVS Caremark's long-term growth to benefit from Healthcare reform laws and for shares to outperform based on limited 2013 negative earnings revisions, a stronger 2014 PBM selling season, and generics. Price target raised to $55 from $50.
News For CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
13:16 EDTCVSPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTCVSLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 22, 2015
10:28 EDTCVSCVS Health April weekly call activity attributed to takeover chatter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use